From navigating the pricing and reimbursement environment to new skills required for Chief Medical Officers, the 8th annual Chief Medical Officer Summit will cover best practices, benchmark ideas and work through R&D challenges in a virtual format from October 26 through October 27. We are pleased to announce TD2’s Vice President of Translational Medicine, Jenny Keppler, will help lead these discussions and speak to prioritizing efficacy in oncology early development trials and the deployment of multiparameter measures of drug activity. She will be speaking at the virtual conference on October 27th at 1:45 PM EST
Our experienced drug development team will work with you through the extensive non-clinical, regulatory, and clinical phases to provide end to end solutions. We encourage you to speak with us via video conferencing at any point to discuss your needs and the diverse solutions we offer.
For additional details, please contact Vice President of Sales, Marc Appelbaum at firstname.lastname@example.org.
We look forward to meeting you and changing the way you think about the drug development process.
October 27, 2020
1:45 p.m. EST